Technical Analysis for LLY - Eli Lilly and Company

Grade Last Price % Change Price Change
B 762.66 1.13% 8.49
LLY closed up 1.13 percent on Monday, March 18, 2024, on 79 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
23 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
Gapped Up Strength 0.00%
NR7 Range Contraction 1.13%
Gapped Down Weakness 1.13%
20 DMA Resistance Bearish 0.25%
New Uptrend Bullish 0.25%
Gapped Up Strength 0.25%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 10 hours ago
60 Minute Opening Range Breakout about 11 hours ago
Up 2% about 13 hours ago
Rose Above 20 DMA about 13 hours ago
20 DMA Resistance about 13 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eli Lilly and Company Description

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company's neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; bipolar depression and treatment-resistant depression; and brain imaging of beta-amyloid plaques. Its endocrinology products treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. The company's oncology products treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as cardiovascular products, which are used treat erectile dysfunction, benign prostatic hyperplasia, high cholesterol, pulmonary arterial hypertension; reduce thrombotic cardiovascular events; and used as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents; antibiotics to control enteric infections in calves and swine; products to treat canine separation anxiety; products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections; and other pharmaceutical products to treat staphylococcal and bacterial infections. The company distributes its products through independent wholesale distributors; and directly to pharmacies. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Diabetes Neuroscience Pharmaceutical Products Alzheimer's Disease Hypertension Mental Health Antibiotics Health Products Animal Health Wholesale Distributor Schizophrenia Dog Dysfunction Milk Major Depressive Disorder Psychiatric Diagnosis Psychiatry Depression Pulmonary Arterial Hypertension Cholesterol Cattle Depressive Disorder Amyloid Bacterial Infections Osteoporosis Animal Health Products Attention Deficit Hyperactivity Disorder Head And Neck Cancer Bipolar Disorder Endocrinology Benign Prostatic Hyperplasia Growth Hormone Helio Hyperactivity Disorder Hyperplasia Obsessive Compulsive Disorder Vascular Products Erectile Dysfunction Growth Hormone Deficiency Mood Disorders Percutaneous Testosterone Treatment Resistant Depression Cardiovascular Products Mesothelioma Bipolar Depression Oncology Products Panic Disorder Percutaneous Coronary Intervention Psychology Respiratory And Other Diseases

Is LLY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 800.78
52 Week Low 320.5763
Average Volume 3,196,649
200-Day Moving Average 577.96
50-Day Moving Average 707.31
20-Day Moving Average 764.39
10-Day Moving Average 762.44
Average True Range 20.45
RSI (14) 56.14
ADX 26.84
+DI 26.97
-DI 22.41
Chandelier Exit (Long, 3 ATRs) 739.44
Chandelier Exit (Short, 3 ATRs) 788.96
Upper Bollinger Bands 791.22
Lower Bollinger Band 737.56
Percent B (%b) 0.47
BandWidth 7.02
MACD Line 12.88
MACD Signal Line 18.94
MACD Histogram -6.0632
Fundamentals Value
Market Cap 724 Billion
Num Shares 949 Million
EPS 5.55
Price-to-Earnings (P/E) Ratio 137.42
Price-to-Sales 20.59
Price-to-Book 62.62
PEG Ratio 1.78
Dividend 4.52
Dividend Yield 0.59%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 779.81
Resistance 3 (R3) 780.24 774.96 776.95
Resistance 2 (R2) 774.96 770.59 774.74 775.99
Resistance 1 (R1) 768.81 767.90 771.89 768.38 775.04
Pivot Point 763.53 763.53 765.07 763.31 763.53
Support 1 (S1) 757.38 759.16 760.46 756.95 750.28
Support 2 (S2) 752.10 756.47 751.88 749.33
Support 3 (S3) 745.95 752.10 748.37
Support 4 (S4) 745.52